Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism

The Journal of Clinical Investigation
W B MendelsonL S Jacobs

Abstract

We have examined the effects of cholinergic blockade with 0.5 mg methscopolamine bromide, intramuscularly, on sleep-related and insulin-induced growth hormone (GH) secretion. 17 normal young men were studied; 8 had sleep studies, and 12 (including 3 who also had sleep studies) had insulin tolerance tests (ITT) with 0.1 U/kg of regular insulin. After an adjustment night in the sleep laboratory, saline control night and methscopolamine night studies were done in random sequence; study procedures included electroencephalographic, electromyographic, and electrooculographic recordings, and blood sampling every 20 min for hormone radioimmunoassays. Prolactin levels were also measured during sleep. For methscopolamine night studies, the mean overall control GH level of 2.89+/-0.44 ng/ml and the mean peak control GH level of 11.09+/-3.11 ng/ml were dramatically reduced to 0.75+/-0.01 and 1.04+/-0.25 ng/ml, respectively (P<0.0001 and <0.001). Despite virtual absence of GH secretion during the night in every study subject, no measured sleep characteristic was affected by methscopolamine, including total slow-wave sleep (12.1+/-2.6% control vs. 10.3+/-2.5% drug, P>0.2). Sleep prolactin levels were not changed by methscopolamine. In contra...Continue Reading

References

Jun 1, 1976·The Journal of Clinical Investigation·K ChiharaH Imura
Jun 1, 1975·Journal of Pharmaceutical Sciences·J B Malick, A Barnett
Sep 1, 1975·The Journal of Clinical Investigation·W B MendelsonW H Daughaday
Oct 1, 1975·Endocrinology·B K McLean, M B Nikitovitch-Winer
Jan 1, 1969·The Journal of Clinical Endocrinology and Metabolism·Y HondaK Shizume
Jun 1, 1969·The Journal of Clinical Endocrinology and Metabolism·D C ParkerL G Rossman
Nov 1, 1973·The Journal of Clinical Endocrinology and Metabolism·G F PowellE S Barratt
Sep 1, 1973·The Journal of Clinical Endocrinology and Metabolism·J F SassinE D Weitzman
Apr 1, 1974·The Journal of Clinical Endocrinology and Metabolism·D C ParkerE F Vanderlaan
Jun 1, 1971·The Journal of Clinical Endocrinology and Metabolism·C Lucke, S M Glick
Nov 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·C Libertun, S M McCann
Mar 1, 1973·The Journal of Clinical Endocrinology and Metabolism·Y N SinhaW P VanderLaan
Jun 1, 1973·The Journal of Clinical Endocrinology and Metabolism·D C ParkerE F Vander Laan
Oct 1, 1973·Metabolism: Clinical and Experimental·M PerlowE D Weitzman
Mar 1, 1974·The Journal of Clinical Endocrinology and Metabolism·D C ParkerR Guillemin
Apr 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·L GrandisonJ Meites
Jan 1, 1974·Hormone Research·E OthmerW H Daughaday
Nov 1, 1971·The Journal of Clinical Endocrinology and Metabolism·C Lucke, S M Glick
Jun 1, 1972·The Journal of Clinical Endocrinology and Metabolism·H E CarlsonF Snyder
Oct 1, 1972·The Journal of Clinical Endocrinology and Metabolism·R L LipmanD H Mintz
Jan 1, 1971·The Journal of Clinical Endocrinology and Metabolism·D C Parker, L G Rossman
Aug 1, 1971·The Journal of Clinical Endocrinology and Metabolism·J J SchnureR L Lipman
Sep 1, 1968·The Journal of Clinical Investigation·Y TakahashiW H Daughaday

Citations

Jan 1, 1980·European Journal of Applied Physiology and Occupational Physiology·J D Few, C T Davies
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·R L Kohl, J L Homick
Jul 1, 1979·Psychiatry Research·N SitaramJ C Gillin
Sep 1, 1986·Neurobiology of Aging·E HollanderK L Davis
Jan 1, 1980·Psychoneuroendocrinology·A R GlassR C Dimond
Jan 1, 1981·Psychoneuroendocrinology·O BenkertC Seibold
Jan 1, 1982·Psychoneuroendocrinology·B M DavisK L Davis
Jan 1, 1982·Psychoneuroendocrinology·A N EliasM K Grossman
Jan 1, 1990·Psychoneuroendocrinology·A CavalloG Cattell-Harvey
Dec 1, 1983·Brain Research Bulletin·K T BorerA I Vinik
Jan 1, 1990·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·J PopovaS Zaharieva
Jan 1, 1984·Journal of the American Academy of Child Psychiatry·L L GreenhillE J Sachar
Jan 1, 1982·Journal of Endocrinological Investigation·A MasalaA Satta
May 12, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Eve Van CauterGeorges Copinschi
Aug 1, 1980·Metabolism: Clinical and Experimental·S A Leveston, P E Cryer
Aug 1, 1986·Metabolism: Clinical and Experimental·H R FishJ T O'Brian
Apr 1, 1985·Clinical Endocrinology·B J TaylorC G Brook
Aug 1, 1986·Clinics in Endocrinology and Metabolism·B B Bercu, F B Diamond
Aug 1, 1994·Clinical Endocrinology·A L Ogilvy-StuartS M Shalet
Nov 1, 1987·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·J Puig-Antich
Jan 1, 1988·Clinical Endocrinology·C DieguezM F Scanlon
Dec 1, 1984·Journal of Endocrinological Investigation·M S ShapiroL Shenkman
Nov 1, 1985·Journal of the American Geriatrics Society·B M DavisK L Davis
Apr 30, 1999·Physiological Reviews·E E MüllerD Cocchi
Jun 1, 1988·Journal of Endocrinological Investigation·G DelitalaR Virdis

Related Concepts

Electroencephalogram
Parasympathetic Nervous System
Prolactin
Scopolamine Derivatives
Sleep, Slow-Wave
Recombinant Growth Hormone

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.